Today: Remembering Whitney, Girls and Reality TV, Stars' Awkward Photos
Sorted by: Top Picks

Steven Nissen considers himself an activist

By Tony on
This CNN article has some background on Steven Nissen and his background as a politically active college student in the 1960s. Nissen has become one of the most famous whistleblowers in the medical field -- raising awareness of health risks associated with Vioxx and Avandia. The article is an interesting read. Linked from http://www.cnn.com/2005/HEALTH/11/01/profile.cardiologist.nissen/index.html --- A glimpse into his background explains a lot. As an undergraduate during the turbulent 1960s...Read Full Story

FDA Asks For “Restraint” On Drug Safety Worries

By pharmafiles on  From thepharmafiles.com
By Matther Herper Ever since cardiologists Steven Nissen and Eric Topol pooled clinical trials to warn about the heart risks of Vioxx in 2001, drug companies have fretted about how outsiders will use their data. The technique of pooling disparate clinical trials, called meta-analysis, has become the most powerful weapon of drug safety researchers. A meta-analysis resulted in Novartis’ bowel drug Zelnorm being yanked, and it was another meta-analysis by Nissen that raised concerns about...Read Full Story

Video: Nissen Says Better Drugs, Not More, Needed in U.S.

By scottpasinski on  From clipsyndicate.com
Jan. 6 (Bloomberg) -- Steven Nissen, head of cardiology at the Cleveland Clinic, discusses the rate of drug approvals by the U.S. Food and Drug Administration. Nissen speaks from Cleveland with Margaret Brennan on Bloomberg Television's "InBusiness." (Source: Bloomberg)Read Full Story

Steven Nissen named to the Time 100

By Tony on
Steven Nissen has sparked serious medical debates about the safety and viability of both Vioxx and Avandia -- two of the hottest medical debates of the year. Time magazine has named him as one of the most influential people of the year, Here's a brief excerpt and link to the main Time article. Linked from http://www.time.com/time/specials/2007/time100/article/0,28804,1595326_1595329_1616143,00.html --- Nissen, 58, a heart specialist at the Cleveland Clinic, started his climb to...Read Full Story

Video: Nissen Says It’s Time To Pull Avandia Off The Market: Video

By scottpasinski on  From clipsyndicate.com
Feb. 22 (Bloomberg) -- Steven Nissen, chairman of cardiology at the Cleveland Clinic, talks with Bloomberg’s Betty Liu and Peter Cook about a Senate report that said GlaxoSmithKline Plc knew the diabetes medicine Avandia may cause heart attacks several years before a study, authored by Nissen, documented the risk. The Senate report, by Senators Max Baucus and Charles Grassley, said the company pressed doctors doctors to retract warnings about side effects.(Source: Bloomberg)Read Full Story
Sorted by: Top Rated

Steve Nissen

Steve Nissen

Linked from: time.com

Editable by Any Member
Photo

Nissen, Steven, M.D.
Chairman, Department of Cardiovascular Medicine
Immediate Past President, American College of Cardiology, Washington, DC

Phone: (216) 445-6852
appointed:1992
medical school:University of Michigan Medical School Ann Arbor, MI
specialty training:Fellowship - University of Kentucky Chandler Medical Center Lexington KY
Internship - University of California Davis Medical Center Sacramento CA
Residency - University of California Davis Medical Center Sacramento CA
other education:B.S. - University of Michigan Ann Arbor MI
specialty interests:intravascular ultrasound, digital angiography and computer image processing, coronary intensive care

Source: Cleveland Clinic
Diane P. Sullivan, the Princeton, N.J.-based litigator who secured a 2005 victory for client Merck in the Vioxx products liability lawsuit, has left Dechert for New York mega-firm Weil Gotshal & Manges. Joining Sullivan in the move is partner Kathleen O’Connor, the former in-house Merck lawyer who ultimately joined Dechert and worked on the Vioxx case. Sullivan, who joined Dechert in 2001 from Lowenstein Sandler, specializes in litigating...  
From bizjournals.com ()
Related news:
More perspectives...
Pharmaceutical giant GlaxoSmithKline has agreed to settle several product liability cases involving its blockbuster diabetes drug Avandia, spokeswoman Bernadette King confirmed Thursday. The company will make payments out of cash already designated to claims involving Avandia. GlaxoSmithKline (NYSE: GSK), which has been facing legal issues relating to Avandia for years, has its North American headquarters in Research Triangle Park and employs...  
From bizjournals.com ()
More perspectives...
GlaxoSmithKline Plc (GSK), which is paying $3 billion to resolve government claims that it illegally marketed drugs such as the Avandia diabetes medication, agreed to settle more lawsuits over the pills, a lawyer said. Glaxo, the U.K.s biggest drugmaker, agreed last month to resolve more than 20,000 cases alleging Avandia causes heart attacks, said Paul Kiesel, a lawyer for former users. The accord...  
From rss.biospace.com ()
Related news:
More perspectives...
Nadrich & Cohen, LLP reports that GlaxoSmithKline has agreed to settle approximately 20,000 Avandia side effects lawsuits. Los Angeles, CA, February 3, 2012 – UK drug-maker GlaxoSmithKline has agreed to settle 20,000 Avandia side effects lawsuits. According to a Bloomberg  
From openpr.com ()
Related news:
More perspectives...
VIOXX DEAL: Merck and lawyers for Canadian Vioxx users have struck a deal, awaiting approval by courts in provinces there, to end lawsuits filed by hundreds of people claiming harm from the drugmaker's recalled painkiller Vioxx.  
From syndication.boston.com ()
More perspectives...
Drugmaker Merck & Co. said Thursday that it has reached a deal to settle all lawsuits in Canada over its recalled painkiller Vioxx, for up to 36.9 million Canadian dollars ($36.5 million). Merck and attorneys representing hundreds of Vioxx users in Canada said the final payment will be at least $21.6 million and could go as high as $36.5 million. Merck and representatives of the plaintiffs have signed...  
From rss.biospace.com ()
Related news:
More perspectives...
As the Republican presidential candidates propose to dismantle President Obama’s 2010 healthcare reform package ... The Fight to Rescue American Health Care,” which is being featured this year at the Sundance Film Festival.  
From api.bing.com ()
Related news:
More perspectives...
Editable by Any Member
If we're missing a great Steven Nissen quoye, please add it by clicking on "edit"

Steven Nissen Quotes:

“The idea that you would see such a huge benefit so quickly is hard to accept.”

“We could still be wrong. That's what has to happen for this drug to move forward.”

“This panel was asleep at the switch.”

“There's only one way: through good science.”

“Physicians ought to take this into account. These drugs are not very forgiving.”

More From Zimbio
Zimbio Entertainment
Copyright © 2012 - Zimbio, Inc. Some rights reserved.
Share
. . .
Follow
. . .